Skip to main content
Log in

Cellular fibronectin and tenascin in experimental perforating scleral wounds with incarceration of the vitreous

  • Laboratory Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: Posterior perforating eye injury carries a high risk of visual loss due to the formation of intravireal and epiretinal scar tissue. Intraocular scar formation in patients with retinal detachment has been shown to be associated with elevated intravitreal FN levels. The extracellular matrix glycoproteins fibronectiu (FN) and tenascin (TN) have been located in epiretinal scar membranes. As both FN and TN are also involved in healing of cutaneous and corneal wounds, we undertook to study their expression in rabbit perforating scleral wounds with vitreous incarceration. • Methods: A perforating scleral wound was produced and sutured without removal of vitreous from the wound in 18 pigmented rabbits. The rabbits were killed at various times (1 h to 21 days) after the operation, and the indirect immunohistochemical method was used for demonstration of FN and TN. Monoclonal mouse hybridoma antibodies 52 DH1 and 100 EB2, recognizing the cellular form of FN (cFN) and TN, respectively, were used. • Results: During the first post-operative week immunoreaction for glycoproteins, both the locally produced cFN and TN, were observed at the scar tissue containing the prolabed vitreous and the adjacent sclera. Subsequently, the reaction gradually shifted to the vitreal side of the wound, and 3 weeks after the operation it was almost completely restricted to a separated mass of vitreous beneath the scar. • Conclusion: The expression of cFN and TN in the scleral scar and vitreous is indicative of their local synthesis. The shift of the expression of those proteins to the vitreal side of the wound with time suggests that the scarring process in the vitreous is delayed compared to the sclera.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Campochiaro PA, Jerdan J, Glaser BM (1984) Serum contains chemo-attractants for human retinal pigment epithelial cells. Arch Ophthalmol 102:1830–1833

    Google Scholar 

  2. Chiquet-Ehrismann R, Mackie EJ, Pearson C, Sakakura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131–139

    Google Scholar 

  3. Chiquet-Ehrismann R, Kalla P, Pearson C, Beck K, Chiquet M (1988) Tenascin interferes with fibronectin action. Cell 53:383–390

    Google Scholar 

  4. Cleary PE, Ryan SJ (1978) Posterior, perforating injury. Experimental animal model. Trans Ophthalmol Soc UK 98:34–37

    Google Scholar 

  5. Daicker B (1985) Constricting retroretinal membranes associated with traumatic retinal detachments. Graefe's Arch Clin Exp Ophthalmol 222:147–153

    Google Scholar 

  6. Erickson H, Lightner VA (1988) Hexabrachion protein (tenascin, cytotactin, brachionectin) in connective tissues, embryonic brain, and tumours. Adv Cell Biol 2:55–90

    Google Scholar 

  7. Erickson H, Bourdon M (1989) Tenascin: an extracellular matrix protein present in specialized embryonic tissues and tumours. Annu Rev Cell Biol 5:71–92

    Google Scholar 

  8. Hiscott P, Waller HA, Grierson I, Butler MG, Scott DL, Gregor Z, Morino I (1992) Fibronectin synthesis in subretinal membranes of proliferative vitreoretinopathy. Br J Ophthalmol 76:486–490

    Google Scholar 

  9. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukolis GL, Gould VE (1990) Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 63:798–806

    Google Scholar 

  10. Immonen I, Salonen E-M, Laatikainen L, Vaheri A (1989) Fibronectin in subretinal fluid. In: Heimann K, Wiedemann P (eds) Proliferative vitreoretinopathy. Kaden, Heidelberg, pp 109–112

    Google Scholar 

  11. Immonen I, Tervo K, Virtanen I, Laatikainen L, Tervo T (1991) Immunohistochemical demonstration of cellular fibronectin and tenascin in human epiretinal membranes. Acta Ophthalmol (Copenh) 69:446–471

    Google Scholar 

  12. Jones FS, Burgoon MP, Hoffman S, Crossin KL, Cunningham BA, Edelman GM (1988) A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA 85:2186–2190

    Google Scholar 

  13. Lotz MM, Burdsal CA, Erickson HP, McClay DR (1989) Cell adhesion to fibronectin and tenascin: quantitative measurement of initial binding and subsequent strengthening response. J Cell Biol 109:1795–1805

    Google Scholar 

  14. Mackie EJ, Halfter W, Liverani D (1988) Induction of tenascin in healing wounds. J Cell Biol 107:2757–2767

    Google Scholar 

  15. Mensing H, Pontz BF, Müller PK, Gauss-Miiller V (1983) A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemo attractants. Eur J Cell Biol 29:268–273

    Google Scholar 

  16. Newsome DA, Pfeffer BA, Hewitt AT, Robey PG, Hassel JR (1988) Detection of extracellular matrix molecules synthesized in vitro by monkey and human retinal epithelium: influence of donor age and multiple passages. Exp Eye Res 46:305–331

    Google Scholar 

  17. Shrakawa H, Yoshimura N, Yamakawa R, Matasumura M, Okada M, Ogina N (1987) Cell components in proliferative vitreoretinopathy: immunofluorescent double staining of cultured cells from proliferative tissue. Ophthalmologica 194:56–62

    Google Scholar 

  18. Tervo K, Tervo T, van Setten G-B, Tarkkanen A, Virtanen I (1989) Demonstration of tenascin-like immunoreactivity in rabbit corneal wounds. Acta Ophthalmol (Copenh) 67:347–350

    Google Scholar 

  19. Tervo K, van Setten G-B, Beuerman RW, Virtanen I, Tarkkanen A, Tervo T (1991) Expression of tenascin and cellular fibronectin in rabbit cornea after anterior keratectomy: immunohistochemical study on wound healing dynamics. Invest Ophthalmol Vis Sci 32:2912–2918

    Google Scholar 

  20. Topping TM, Abrams GW, Machemer R (1979) Experimental double-perforating injury of the posterior segment in rabbit eyes: the natural history of intraocular proliferation. Arch Ophthalmol 97:735–742

    Google Scholar 

  21. Vaheri A, Salonen E-M, Vartio T (1985) Fibronectin in formation and degradation of the pericellular matrix. In: Evered D, Whela J (eds) Fibrosis, Ciba Foundation Symposium 44. Pitman, London, pp 111–126

    Google Scholar 

  22. Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L, Virtanen I (1987) Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88:419–430

    Google Scholar 

  23. Weller M, Wiedemann P, Heimann K, Zilles K (1988) The significance of fibronectin in vitreoretinal pathology. A critical evaluation. Graefe's Arch Clin Exp Ophthalmol 226:294–298

    Google Scholar 

  24. Yeo JH, Sadeghi J, Campochiaro PA, Green WR, Glaser B (1988) Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment. Arch Ophthalmol 104:417–421

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tervo, K., Latvala, T., Suomalainen, VP. et al. Cellular fibronectin and tenascin in experimental perforating scleral wounds with incarceration of the vitreous. Graefe's Arch Clin Exp Ophthalmol 233, 168–172 (1995). https://doi.org/10.1007/BF00166610

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00166610

Keywords

Navigation